SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-09-007495
Filing Date
2009-08-10
Accepted
2009-08-10 16:21:21
Documents
10
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2194024z10-q.htm 10-Q 625349
2 EXHIBIT 10.1 a2194024zex-10_1.htm EX-10.1 440784
3 EXHIBIT 10.2 a2194024zex-10_2.htm EX-10.2 99714
4 EXHIBIT 31.1 a2194024zex-31_1.htm EX-31.1 7551
5 EXHIBIT 31.2 a2194024zex-31_2.htm EX-31.2 7566
6 EXHIBIT 32.1 a2194024zex-32_1.htm EX-32.1 4189
7 G184192MM01I001.JPG g184192mm01i001.jpg GRAPHIC 2359
8 G184192MM01I002.JPG g184192mm01i002.jpg GRAPHIC 2590
9 G184192MM01I003.JPG g184192mm01i003.jpg GRAPHIC 2357
10 G184192MM05I001.JPG g184192mm05i001.jpg GRAPHIC 634
  Complete submission text file 0001047469-09-007495.txt   1198059
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 091000166
SIC: 2834 Pharmaceutical Preparations